GoodRx Holdings (GDRX) | Stock Overview & Key Data
GoodRx Holdings Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $64.22 on September 28, 2020
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
GoodRx Holdings
GDRX
|
787.92M Small-cap | -1.75% | 12.40% | 35.75% | 2.55% | 2.18% | -25.51% | -45.83% | -92.39% | -94.39% | -94.39% | -94.39% |
|
Ge Healthcare
GEHC
|
31.89B Large-cap | -2.90% | 1.69% | -20.61% | -25.79% | -25.10% | -11.62% | -22.05% | 9.87% | 9.87% | 9.87% | 9.87% |
|
Veeva Systems
VEEV
|
26.49B Large-cap | 12.76% | 4.99% | -3.87% | -25.94% | -18.57% | -37.67% | -10.59% | -39.53% | 399.40% | 292.75% | 292.75% |
|
Omnicell
OMCL
|
1.65B Small-cap | -2.85% | -3.57% | 2.67% | 3.48% | -7.20% | 45.34% | -40.34% | -68.37% | 35.61% | 212.38% | 209.75% |
|
Teladoc Health
TDOC
|
1.04B Small-cap | 7.59% | 6.94% | 39.02% | -5.84% | 0.57% | 9.97% | -68.91% | -94.81% | -35.62% | -72.82% | -72.82% |
|
Certara
CERT
|
969.01M Small-cap | 4.67% | -9.53% | -22.65% | -42.15% | -35.93% | -48.77% | -73.18% | -77.81% | -84.72% | -84.72% | -84.72% |
Ownership & Short Interest
Calculate Your GoodRx Holdings Investment Returns
Long-Term Investment Performance Analysis
GoodRx Holdings stock price in Sep 2020 was $52.04, A $1,000.00 lump sum investment in GoodRx Holdings made 5 years ago would be worth approximately $54.00 today, representing a negative return of -94.60%. This translates to an annualized return (CAGR) of -40.09%.
5 Years 8 Months Investment Scenario (Sep 2020 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is GDRX's 52-week high and low?
- In the last 52 weeks, GoodRx Holdings reached a high of $5.81 (on October 9, 2025) and a low of $1.77 (on March 2, 2026).
- What is the market cap and P/E ratio for GDRX?
- Curious about GoodRx Holdings's size and valuation? Its market capitalization stands at 787.92M. When it comes to valuation, the P/E ratio (trailing twelve months) is 25.67, and the forward P/E (looking ahead) is 6.29.
- Does GDRX pay dividends? If so, what's the yield?
- As for dividends, GoodRx Holdings isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are GoodRx Holdings's main competitors or similar companies to consider before investing?
When looking at GoodRx Holdings, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Ge Healthcare
GEHC31.89B Healthcare Health Information Services -11.62% -22.05% Veeva Systems
VEEV26.49B Healthcare Health Information Services -37.67% -10.59% Omnicell
OMCL1.65B Healthcare Health Information Services 45.34% -40.34% Teladoc Health
TDOC1.04B Healthcare Health Information Services 9.97% -68.91% Certara
CERT969.01M Healthcare Health Information Services -48.77% -73.18% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for GoodRx Holdings Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of GoodRx Holdings's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 4.54%, the Debt to Equity ratio from the most recent quarter is 88.08, and its Gross Profit Margin stands at 91.03%.
- What is the recent revenue and earnings growth for GDRX?
- Looking at GoodRx Holdings's growth, its revenue over the trailing twelve months (TTM) was $797M. Compared to the same quarter last year (YoY), quarterly revenue grew by -1.90%, and quarterly earnings saw a YoY growth of -19.50%.
- How much of GDRX stock is held by insiders and institutions?
- Wondering who owns GoodRx Holdings stock? Company insiders (like executives and directors) hold about 12.57% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 58.17%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.